Skip to main content
Premium Trial:

Request an Annual Quote

UC Davis, Whitney Laboratory, DNAStar

Premium
UC Davis Fiehn Laboratory to Use Genedata’s Refiner MS and Analyst Software
 
Genedata will partner with the Fiehn Laboratory at the University of California, Davis to provide the former’s Expressionist software platform for biomarker discovery. Both Refiner MS and Analyst modules will be used for mass spectrometry-based metabolomics analyses to classify patient samples and identify biomarkers.
 
Genedata’s Refiner MS software module performs high-throughput processing and automated quality analysis of mass spectrometry-based proteomics and metabolomics data. Refiner MS affords rapid processing of hundreds of gigabytes of data simultaneously, while Analyst touts a comprehensive statistical analysis platform that allows these processed data to be compared with microarrays, bead-based assays, qPCR, 2D-PAGE, 2D-DIGE and NMR data, as well as additional types of MS data. This integrated view helps researchers to understand the action of all biomolecules in a single, comprehensive system, the company said. 
 

 
Whitney Lab for Marine Bioscience and DNAStar
Sign Software Site License Agreement
 
DNAStar has signed a site license agreement with the Whitney Laboratory for Marine Bioscience in St. Augustine, Fla.,for the use of the company’s Lasergene sequence analysis software. Under terms of the agreement, scientists at the institute will be able to use the most current version of DNAStar’s Lasergene software for four years.   
 
Lasergene is a comprehensive suite of tools for molecular biologists and geneticists. It is used primarily in the assembly and analysis of DNA and protein sequences.
 

Currently, DNASTAR produces Lasergene, a sequence analysis software suite; GenVision, a data visualization software application; and ArrayStar, a microarray gene expression visualization tool. 

Filed under

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.